Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt · Delayed Price · Currency is EGP 298.24
-4.06 (-1.34%)
At close: Oct 22, 2026
EGX:MPCI Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 6,785 | 5,418 | 1,684 | 505 | 174 | 78 | |
Market Cap Growth | 31.48% | 221.72% | 233.20% | 190.25% | 123.70% | -48.16% |
Enterprise Value | 6,247 | 5,078 | 1,090 | 220 | 403 | -31 |
Last Close Price | 298.24 | 238.17 | 69.65 | 26.25 | 8.72 | 3.90 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.13 | 11.29 | 3.33 | 2.64 | 1.93 | 1.05 |
PS Ratio | 3.98 | 3.18 | 1.12 | 0.58 | 0.26 | 0.14 |
PB Ratio | 8.05 | 6.43 | 2.19 | 3.39 | 1.66 | 2.13 |
P/TBV Ratio | 8.06 | 6.44 | 2.20 | 3.60 | 1.88 | 3.79 |
P/FCF Ratio | 36.60 | 29.23 | 25.65 | 3.18 | 3.75 | 3.31 |
P/OCF Ratio | 30.80 | 24.60 | 19.38 | 2.76 | 3.01 | 2.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 3.66 | 2.98 | 0.72 | 0.25 | 0.61 | - |
EV/EBITDA Ratio | 11.47 | 9.32 | 1.94 | 0.98 | 3.89 | - |
EV/EBIT Ratio | 11.93 | 9.70 | 2.01 | 1.04 | 4.21 | - |
EV/FCF Ratio | 33.69 | 27.39 | 16.61 | 1.39 | 8.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.12 | 1.19 | 0.13 | 0.13 |
Debt / EBITDA Ratio | 0.13 | 0.13 | 0.17 | 0.79 | 0.13 | 0.06 |
Debt / FCF Ratio | 0.39 | 0.39 | 1.45 | 1.12 | 0.29 | 0.20 |
Net Debt / Equity Ratio | -0.64 | -0.64 | -0.76 | -2.30 | -1.24 | -2.16 |
Net Debt / EBITDA Ratio | -0.99 | -0.99 | -1.04 | -1.53 | -1.26 | -1.03 |
Net Debt / FCF Ratio | -2.90 | -2.90 | -8.89 | -2.16 | -2.80 | -3.36 |
Asset Turnover | 1.14 | 1.14 | 1.11 | 0.87 | 0.99 | 1.11 |
Inventory Turnover | 2.24 | 2.24 | 2.33 | 2.40 | 2.29 | 2.41 |
Quick Ratio | 1.24 | 1.24 | 1.34 | 0.90 | 0.71 | 0.39 |
Current Ratio | 2.30 | 2.30 | 2.15 | 1.16 | 1.03 | 0.92 |
Return on Equity (ROE) | 59.48% | 59.48% | 109.89% | 150.74% | 127.74% | - |
Return on Assets (ROA) | 21.94% | 21.94% | 25.03% | 13.20% | 8.91% | 8.70% |
Return on Invested Capital (ROIC) | 137.11% | 170.04% | - | - | - | - |
Return on Capital Employed (ROCE) | 58.50% | 58.50% | 64.30% | 81.00% | 88.10% | 180.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 7.07% | 8.86% | 30.00% | 37.88% | 51.93% | 95.17% |
FCF Yield | 2.73% | 3.42% | 3.90% | 31.42% | 26.70% | 30.25% |
Dividend Yield | 4.42% | 5.54% | 17.81% | 4.45% | 6.46% | - |
Payout Ratio | 68.54% | 68.54% | 5.05% | 6.35% | - | - |
Buyback Yield / Dilution | 0.06% | 0.06% | -304.63% | - | - | - |
Total Shareholder Return | 4.48% | 5.60% | -286.81% | 4.45% | 6.46% | - |